Atoltivimab (REGN3470), also known as maftivimab/odesivimab under the brand name Inmazeb, is distinguished as the first monoclonal antibody approved by the U.S. Food and Drug Administration (FDA) for targeting Zaire ebolavirus (EBOV) infections. This therapeutic agent is specifically designed to neutralize the virus, providing a critical tool in the management and treatment of Ebola virus disease.
Atoltivimab (REGN3470), also known as maftivimab/odesivimab under the brand name Inmazeb, is distinguished as the first monoclonal antibody approved by the U.S. Food and Drug Administration (FDA) for targeting Zaire ebolavirus (EBOV) infections. This therapeutic agent is specifically designed to neutralize the virus, providing a critical tool in the management and treatment of Ebola virus disease.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
